Abstract 6809: Tumor-associated macrophages promote bladder cancer cell migration and invasion through activation of CCL20-CCR6 axis

20立方厘米 C-C趋化因子受体6型 癌症 癌症研究 膀胱癌 医学 微生物学 生物 免疫学 趋化因子 内科学 炎症 趋化因子受体
作者
Ryunosuke Nakagawa,Kouji Izumi,Ren Toriumi,Shuhei Aoyama,Taiki Kamjima,Hiroshi Kano,Tomoyuki Makino,Renato Naito,Hiroshi Yaegashi,Takahiro Nohara,Hiroki Nakata,Atsushi Mizokami
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 6809-6809
标识
DOI:10.1158/1538-7445.am2024-6809
摘要

Abstract We focused on Tumor-Associated Macrophages (TAM) and explored its effects on bladder cancer (BC). Co-culturing PMA-treated THP-1 with BC cell lines (UMUC3 and T24) induced THP-1 to develop suppressed CD68 and increased CD206 expression which differentiated into M2-like macrophages. Co-culture of BC with TAM of this M2-like macrophage enhanced the migration and invasive activities of BC, as well as the expression of EMT marker. Human cytokine antibody array of conditioned medium from the co-culture of BC and TAM showed high CCL20, CCL2 and CXCL7. qPCR revealed that these chemokines were mainly derived from TAMs, not BC. Only CCL20 enhanced the migration and invasion of BC and the expression of EMT markers when each of these three recombinant chemokines was administered to BC. Furthermore, inhibiting CCR6, a receptor specific for CCL20, suppressed migration and invasion as expected. In BC, TAMs promote progression and metastasis by secreting CCL20, and inhibition of CCR6 may be one potential therapeutic approach to suppress BC activity. Citation Format: Ryunosuke Nakagawa, Izumi Kouji, Ren Toriumi, Shuhei Aoyama, Taiki Kamjima, Hiroshi Kano, Tomoyuki Makino, Renato Naito, Hiroshi Yaegashi, Takahiro Nohara, Hiroki Nakata, Atsushi Mizokami. Tumor-associated macrophages promote bladder cancer cell migration and invasion through activation of CCL20-CCR6 axis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 6809.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava应助科研通管家采纳,获得10
刚刚
Owen应助严宝宝采纳,获得10
刚刚
所所应助科研通管家采纳,获得20
刚刚
JamesPei应助科研通管家采纳,获得10
刚刚
geng应助科研通管家采纳,获得10
刚刚
Orange应助科研通管家采纳,获得10
刚刚
刚刚
彭于晏应助科研通管家采纳,获得10
刚刚
露露娜娜发布了新的文献求助10
1秒前
bkagyin应助科研通管家采纳,获得10
1秒前
1秒前
难过台灯发布了新的文献求助10
1秒前
Ava应助科研通管家采纳,获得10
1秒前
小二郎应助傅立叶采纳,获得10
1秒前
1秒前
1秒前
科研通AI6.4应助iiiio采纳,获得10
1秒前
开心砖头发布了新的文献求助10
1秒前
上课看发布了新的文献求助10
4秒前
orixero应助1111111采纳,获得10
4秒前
QJZ发布了新的文献求助10
4秒前
5秒前
田様应助栩栩采纳,获得10
5秒前
xiaoshuai完成签到,获得积分10
6秒前
Roger发布了新的文献求助10
6秒前
终陌发布了新的文献求助10
6秒前
长情晟睿发布了新的文献求助10
7秒前
啵啵发布了新的文献求助10
7秒前
7秒前
shijiu完成签到,获得积分10
8秒前
温庭筠完成签到,获得积分10
8秒前
liliy完成签到,获得积分20
9秒前
ghw应助阳光下的星星采纳,获得10
9秒前
9秒前
完美世界应助绵绵采纳,获得10
9秒前
hello完成签到,获得积分10
10秒前
聪明蛋挞应助囧囧啦采纳,获得10
10秒前
Nole应助mm采纳,获得10
11秒前
Nole应助mm采纳,获得10
11秒前
Nole应助mm采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 600
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Rosenblum, Global Change Biology 500
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7770915
求助须知:如何正确求助?哪些是违规求助? 9313753
关于积分的说明 20335060
捐赠科研通 7356211
什么是DOI,文献DOI怎么找? 3316589
关于科研通互助平台的介绍 2465174
邀请新用户注册赠送积分活动 2331459